Skip to navigation Skip to main content
Home
  • About us
    • Organization
    • Coordinator
    • Management board
    • Scientific Council
    • External Advisory Committee
    • Bibliometric & Financing Office
    • Data Science Office
    • Communication and Public Engagement
    • TOXRUN Bylaws
    • Affiliated Journals
    • Collaborations
      • National collaborations
      • International collaborations
    • Reports
    • Contacts
    • People
    • Jobs & Opportunities
  • Mission
  • Projects
  • Publications
    • All publications
    • Papers in scientific journals
    • Book and book chapters
    • Patents
  • Ethics & Integrity
    • TERIO
    • IUCS Ethics Committee
    • ORBEA
  • ORBEA
  • Training
    • Doctoral Programs
    • Master Degrees
    • Advanced courses
    • Events
      • Congresses
      • Seminars
      • Workshops
  • Facilities & Services
    • Laboratories
    • Equipments
    • Services
  • Media
    • News
    • Press
    • TOXRUN Newsletters
  • Science & Society

Search form

  • Breaking

    the boundaries between basic and clinical sciences

    Click here

  • Improving

    health with the power of the scientific discovery

    Click here

  • Investigating

    the causes, diagnosis, treatment and prevention of human diseases

    Click here

  • Serving

    the society. Sharing the knowledge

    Click here

Welcome to Toxicology Research Unit

The R&D Unit of IUCS

 

Save the date:

Banner IITORUN CONGRESS2023.png

II TOXRUN International Congress 2023 | 27th and 28th of April 2023, Porto-Portugal
 
NO BOUNDARIES FOR TOXICOLOGY: ONE HEALTH, ONE SOCIETY, ONE PLANET


 

light-4297386_1920.jpg

Projects

newspaper-973049_1920 n.jpg

News

financial-2860753_1920.jpg

Publications

lABORATORIOS.jpg

Facilities & Services

 

Overcoming Cisplatin Resistance in Non-Small Cell Lung Cancer with Mad2 Silencing siRNA Delivered Systemically using EGFR-Targeted Chitosan Nanoparticles.

  • admin-cespu
  • February 05, 2018
  • 0 comment(s)
  • Read more about Overcoming Cisplatin Resistance in Non-Small Cell Lung Cancer with Mad2 Silencing siRNA Delivered Systemically using EGFR-Targeted Chitosan Nanoparticles.

A comparative analysis of oral and maxillofacial pathology over a 16-year period, in the north of Portugal.

  • admin-cespu
  • February 05, 2018
  • 0 comment(s)
  • Read more about A comparative analysis of oral and maxillofacial pathology over a 16-year period, in the north of Portugal.

Oral rehabilitation with an implant-supported mesostructure on a microvascularized mandibular graft: A 12-year follow-up study.

  • admin-cespu
  • February 05, 2018
  • 0 comment(s)
  • Read more about Oral rehabilitation with an implant-supported mesostructure on a microvascularized mandibular graft: A 12-year follow-up study.

Pages

  • « first
  • ‹ previous
  • …
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • …
  • next ›
  • last »

Contact info

E-mail: toxrun@iucs.cespu.pt

Address: Avenida Central de Gandra, 1317

4585-116 Gandra PRD, Portugal

GPS:41.183509, -8.445928 | N 41° 11′ 0.6324″, W 8° 26′ 45.3408″

Telephone: +351 224 157 100/189/224 (chamada para rede fixa nacional)

TOXRUN and IUCS in social media

Management institution

logo_iucs_cor.png

TOXRUN © 2023 Política de privacidade e termos de uso